Related Experiment Video
Updated: Mar 9, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Microbiota and prebiotics modulation of uremic toxin generation
Laetitia Koppe1, Denis Fouque2
1Department of Nephrology, Centre Hospitalier Lyon Sud, Cardiovascular, Metabolism, Diabetology and Nutrition (CarMeN) Lab, European Center for Nutrition and Health (CENS), University of Lyon, Lyon, France.
Prebiotics may help manage chronic kidney disease (CKD) by improving gut health and reducing harmful uremic retention solutes (URS). More research is needed to confirm their clinical effectiveness in CKD patients.
Area of Science:
- Nephrology
- Gastroenterology
- Microbiome Research
Background:
- The gut microbiota plays a crucial role in overall health, and its disruption (dysbiosis) is linked to chronic kidney disease (CKD) progression.
- Gut dysbiosis contributes to the accumulation of uremic retention solutes (URS) in CKD patients.
- The kidney-gut axis highlights potential therapeutic targets for nutritional interventions.
Purpose of the Study:
- To review the interconnection between CKD, dysbiosis, and URS production.
- To discuss the mechanisms and efficacy of prebiotics in managing CKD.
- To emphasize the role of prebiotics in modulating URS generation.
Main Methods:
- Literature review of animal and human studies on prebiotic interventions in CKD.
- Analysis of the impact of prebiotics on gut microbiota composition and URS levels.
- Evaluation of existing evidence regarding the efficacy of prebiotics for CKD management.
Main Results:
- Dysbiosis is a significant factor in URS accumulation in CKD.
- Prebiotics show potential in influencing URS production and concentration.
- Current evidence from high-quality intervention trials is limited.
Conclusions:
- Prebiotics represent a promising nutritional strategy for CKD management via the kidney-gut axis.
- Further randomized controlled trials are necessary to establish clinical recommendations for prebiotic use in CKD.
- Targeting gut dysbiosis with prebiotics could be a novel approach to mitigate CKD progression and URS burden.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Microorganisms in Medicine and Therapeutics
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Urinary Tract Infection II: Pathophysiology

